MYRIAD GENETICS, INC. Shareholders' Equity
MYRIAD GENETICS, INC. (MYGN) had Shareholders' Equity of $303.90 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-07-31
- 2026-06-30: Stockholders' Equity Attributable to Parent $303.90M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $337.40M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $368.00M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $372.80M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $303.90M 10-Q · filed 2026-07-31 | |
| 2026-03-31 | $337.40M 10-Q · filed 2026-07-31 | |
| 2025-12-31 | $368.00M 10-Q · filed 2026-07-31 | |
| 2025-09-30 | $372.80M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $388.10M 10-Q · filed 2026-07-31 | |
| 2025-03-31 | $704.90M 10-Q · filed 2026-07-31 | |
| 2024-12-31 | $701.10M 10-Q · filed 2026-07-31 | |
| 2024-09-30 | $731.70M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $740.50M 10-Q · filed 2025-11-04 | |
| 2024-03-31 | $760.00M 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $783.20M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $683.40M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $735.20M 10-Q · filed 2024-11-08 | |
| 2023-03-31 | $835.20M 10-Q · filed 2024-11-08 | |
| 2022-12-31 | $885.80M 10-K · filed 2026-02-24 | |
| 2022-09-30 | $916.60M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $947.40M 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $950.10M 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $967.80M 10-K · filed 2025-02-28 | |
| 2021-09-30 | $968.60M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $902.50M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $875.20M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $881.00M 10-K · filed 2024-02-28 | |
| 2020-09-30 | $909.30M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $918.20M 10-KT · filed 2021-03-16 | |
| 2020-03-31 | $967.20M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $1.08B 10-Q · filed 2020-02-07 | |
| 2019-09-30 | $1.07B 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $1.09B 10-KT · filed 2021-03-16 | |
| 2019-03-31 | $1.08B 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $1.06B 10-Q · filed 2019-02-06 | |
| 2018-09-30 | $1.10B 10-Q · filed 2019-02-06 | |
| 2018-06-30 | $966.10M 10-K · filed 2019-08-13 | $964.90M 10-K · filed 2018-08-24 |
| 2018-03-31 | $948.30M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $914.20M 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $870.90M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $768.40M 10-K · filed 2018-08-24 | $778.20M 10-K · filed 2017-08-09 |
| 2017-03-31 | $748.20M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $732.90M 10-Q · filed 2017-02-08 | |
| 2016-09-30 | $735.50M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $739.60M 10-K · filed 2018-08-24 | $748.10M 10-K · filed 2016-08-10 |
| 2016-03-31 | $770.20M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $770.80M 10-Q · filed 2016-02-03 | |
| 2015-09-30 | $687.10M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $661.70M 10-K · filed 2018-08-24 | $662.10M 10-K · filed 2015-08-12 |
| 2015-03-31 | $668.90M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $694.24M 10-Q · filed 2015-02-04 | |
| 2014-09-30 | $712.15M 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $719.00M 10-K · filed 2017-08-09 | $719.00M 10-K · filed 2014-08-13 |
| 2014-03-31 | $722.24M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $675.97M 10-Q · filed 2014-02-05 | |
| 2013-09-30 | $690.27M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $728.60M 10-K · filed 2016-08-10 | $728.59M 10-K · filed 2013-08-14 |
| 2013-03-31 | $664.93M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $662.12M 10-Q · filed 2013-02-06 | |
| 2012-09-30 | $635.57M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $635.80M 10-K · filed 2015-08-12 | $635.66M 10-K · filed 2012-08-15 |
| 2012-03-31 | $652.19M 10-Q · filed 2012-05-02 | |
| 2011-12-31 | $616.76M 10-Q · filed 2012-02-01 | |
| 2011-09-30 | $578.99M 10-Q · filed 2011-11-02 | |
| 2011-06-30 | $566.79M 10-K · filed 2014-08-13 | |
| 2011-03-31 | $524.46M 10-Q · filed 2011-05-04 | |
| 2010-12-31 | $561.10M 10-Q · filed 2011-02-01 | |
| 2010-09-30 | $571.11M 10-Q · filed 2010-11-03 | |
| 2010-06-30 | $557.58M 10-K · filed 2013-08-14 | |
| 2009-06-30 | $434.22M 10-K · filed 2012-08-15 | |
| 2008-06-30 | $425.65M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |